Table 1 The contents (%) of active constituents in different Chinese medicinal materials in daodi production region and non-daodi production regions
From: The scientific elucidation of daodi medicinal materials
No. | CMM | Active constituents | Content (%) | References | ||||
|---|---|---|---|---|---|---|---|---|
Daodi production region | Non-daodi production region | |||||||
1 | Fraxinus chinensis Roxb. | Aesculin, aesculetin | Shaanxi: aesculin (4.37%), aesculetin (1.92%) | Sichuan: aesculin (1.10%), aesculetin (0.21%) | Liaoning: aesculin (2.21%), aesculetin (0.19%) | |||
2 | Astragalus membranaceus (Fisch.) Bge. | Astragaloside | Shanxi: 0.37% | Shandong: 0.12% | Inner Mongolia: 0.11% | Hebei: 0.29% | Jilin: 0.32% | [60] |
3 | Rehmannia glutinosa Libosch. | Catalpol | Henan: 0.76% | Xianyang, Shaanxi: 0.34% | Dali, Shaanxi: 0.33% | [61] | ||
4 | Amomum villosum Lour. | Bornyl acetate | Yangchun, Guangdong: 65.82% | Gaozhou, Guangdong: 55.95% | Guangxi: 61.75% | Yunnan: 50.92% | Burma: 60.71% | |
5 | Pogostemon cablin (Blanco) Benth. | Pogostone | Shipai, Guangzhou, Guangdong: 68.43% | Gaoyao, Zhaoqing, Guangdong: 26.15% | Leizhou, Zhanjiang, Guangdong: 4.78% | Wuchuan, Zhanjiang, Guangdong: 5.20% | Hainan: 8.97% | |